We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society.
- Authors
French, Jacqueline A; Kanner, Andres M; Bautista, Jocelyn; Abou-Khalil, Bassel; Browne, Thomas; Harden, Cynthia L; Theodore, William H; Bazil, Carl; Stern, John; Schachter, Steven C; Bergen, Donna; Hirtz, Deborah; Montouris, Georgia D; Nespeca, Mark; Gidal, Barry; Marks, William J, Jr; Turk, William R; Fischer, James H; Bourgeois, Blaise; Wilner, Andrew; Faught, R Edward, Jr; Sachdeo, Rajesh C; Beydoun, Ahmad; Glauser, Tracy A; American Academy of Neurology Therapeutics and Technology Assessment Subcommittee; American Academy of Neurology Quality Standards Subcommittee; American Epilepsy Society Therapeutics and Technology Assessment Subcommittee; American Epilepsy Society Quality Standards Subcommittee
- Abstract
To assess the evidence demonstrating efficacy, tolerability, and safety of seven new antiepileptic drugs (AEDs) [gabapentin (GBP), lamotrigine (LTG), topiramate (TPM), tiagabine (TGB), oxcarbazepine (OXC), levetiracetam (LEV), and zonisamide (ZNS)] in the treatment of children and adults with refractory partial and generalized epilepsies.
- Publication
Epilepsia, 2004, Vol 45, Issue 5, p410
- ISSN
0013-9580
- Publication type
Journal Article
- DOI
10.1111/j.0013-9580.2004.06304.x